Compare Inovio Pharmaceuticals Inc (INO) vs LifeStance Health Group Inc. Common Stock (LFST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs LifeStance Health Group Inc. Common Stock — how do they compare? Inovio Pharmaceuticals Inc trades at $1.15 (market cap $112.19M), while LifeStance Health Group Inc. Common Stock trades at $12.42 (market cap $4.58B). The key difference: LifeStance Health Group Inc. Common Stock is far larger — about 40.8× Inovio Pharmaceuticals Inc's market cap, and LifeStance Health Group Inc. Common Stock is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Inovio Pharmaceuticals Inc for 43 Days and LifeStance Health Group Inc. Common Stock for 1 Days on average.
| INO | LFST | |
|---|---|---|
Market Cap | $112.19M | $4.58B |
Volume | 3,201,278 | 2,356,698 |
Sector | Health | Health |
52-Week High | $2.60 | $13.38 |
52-Week Low | $0.66 | $4.81 |
Typical Hold Time | 43 Days | 1 Days |
Enterprise Value | $83.51M | $4.82B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO trades at $1.09, down 5.63% today, with a bearish technical outlook and negative financial metrics including a net income margin of -130,000% and ROE of -409.87%. The company faces significant fundamental challenges with minimal revenue of $65,340 and substantial losses, though recent earnings have beaten expectations. Key near-term catalyst is the FDA decision on INO-3107 by October 30, 2026.
Despite analyst consensus favoring Buy ratings (58.83%) with a $2.75 price target, INO carries high risk due to persistent cash burn, negative profitability, and dependency on regulatory approvals. The stock offers speculative upside if INO-3107 gains approval but remains vulnerable to further dilution and operational setbacks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About LifeStance Health Group Inc. Common Stock
LifeStance Health provides outpatient mental healthcare, including therapy, psychiatry, and medication management services.
Read more on LFST →
